Back | Next |
home / stock / nuwe / nuwe message board
Subject | By | Source | When |
---|---|---|---|
Squeeze the manipulation criminals is on the menu list. | trendzone | investorshub | 12/17/2022 2:06:38 PM |
Monday should be good | bowlfan912 | investorshub | 12/17/2022 1:03:32 AM |
Yes I see it now and pre R/S | Roily23 | investorshub | 12/16/2022 10:59:09 PM |
I guess this is what went on and | Roily23 | investorshub | 12/16/2022 10:55:16 PM |
A 100:1 split occurred $NUWE was under $1 | db101 | investorshub | 12/16/2022 10:53:13 PM |
What am I missing as the PPS has | Roily23 | investorshub | 12/16/2022 10:48:07 PM |
NUWE is the next$ COSM! Nuwellis, Inc. reported | Babubd | investorshub | 12/16/2022 8:48:43 PM |
more than 3x undervalued | db101 | investorshub | 12/16/2022 10:48:09 AM |
holding tight with stocks in hand cause when | db101 | investorshub | 12/16/2022 10:43:00 AM |
I got in at 10.20 sold at stop | dinogreeves | investorshub | 12/15/2022 3:52:45 PM |
You should have waited for your movement after | imanjen13 | investorshub | 12/15/2022 3:50:32 PM |
The pre looks good lets see how the | db101 | investorshub | 12/15/2022 11:35:31 AM |
The timing its not ready. Perhaps the new | db101 | investorshub | 12/15/2022 9:27:32 AM |
Why is this trading so poorly? | peeved | investorshub | 12/15/2022 12:40:54 AM |
High chance of good double and probably see | dinogreeves | investorshub | 12/13/2022 11:48:53 PM |
thats revenue growth | db101 | investorshub | 12/13/2022 11:16:41 PM |
Analysts see $NUWE having a 5x year to | db101 | investorshub | 12/13/2022 11:15:04 PM |
Take that shorty! Haha! | HolesInMyPockitz | investorshub | 12/13/2022 5:45:22 PM |
$12 million cash; $3m market cap. Shorty will | HolesInMyPockitz | investorshub | 12/12/2022 10:07:18 PM |
$NUWE is undervalued | db101 | investorshub | 12/12/2022 7:20:11 PM |
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, July 17, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, is proud to announce its first commercial sale of QUELIMMUNE™, a novel therapy developed by SeaS...
DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale of QUELIMMUNE ™ -Pediatric to its U.S. license and distribution partner, Nuwellis, Inc. QUELIMMUNE is SeaStar Medical’s Sel...
MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that new clinical evidence demonstrating the efficacy of its Aquadex ...